Comparison of Health-related Quality of Life Between Double-door Laminoplasty and Selective Laminoplasty for Degenerative Cervical Myelopathy, With a Minimum Follow-up of 5 Years.


Journal

Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646

Informations de publication

Date de publication:
15 02 2019
Historique:
pubmed: 31 7 2018
medline: 26 7 2019
entrez: 31 7 2018
Statut: ppublish

Résumé

A retrospective analysis of prospectively collected multicenter observational data. The aim of this study was to compare the health-related quality of life (HR-QOL) of double-door laminoplasty (DDL) and selective laminoplasty (SL) in patients with degenerative cervical myelopathy (DCM) in two institutions, with a minimum follow-up of 5 years. No study has compared DDL and SL regarding postoperative HR-QOL with a follow-up of more than 5 years. One-hundred ninety patients who underwent DDL (n = 77) or SL (n = 113) participated in this study. Short-form 36 (SF-36), Japanese Orthopedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), Neck Disability Index (NDI), and visual analog scale (VAS) values were compared between the groups. Thirty-seven DDL and 52 SL patients were evaluated. The mean follow-up period was 8 years and the follow-up rate was 46.8%. No significant differences were found regarding age and JOA score at baseline. At the follow-up, there were no significant differences in SF-36, JOACMEQ, and VAS score, while the NDI score for headache and sleeping were higher in the SL group. After dividing the SL group into short and long SL subgroups, the long SL subgroup showed a significantly lower score in bodily pain in SF-36, lower and bladder function in JOACMEQ, and pain intensity, personal care, headaches, and sleeping in NDI compared with the other groups. No significant differences were found in SF-36, JOA score, and NDI, except for the NDI subscale of headache and sleeping. The subgroup analysis showed that the long SL group showed a decreased QOL compared with the short SL and DDL groups. 3.

Sections du résumé

STUDY DESIGN
A retrospective analysis of prospectively collected multicenter observational data.
OBJECTIVE
The aim of this study was to compare the health-related quality of life (HR-QOL) of double-door laminoplasty (DDL) and selective laminoplasty (SL) in patients with degenerative cervical myelopathy (DCM) in two institutions, with a minimum follow-up of 5 years.
SUMMARY OF BACKGROUND DATA
No study has compared DDL and SL regarding postoperative HR-QOL with a follow-up of more than 5 years.
METHODS
One-hundred ninety patients who underwent DDL (n = 77) or SL (n = 113) participated in this study. Short-form 36 (SF-36), Japanese Orthopedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), Neck Disability Index (NDI), and visual analog scale (VAS) values were compared between the groups.
RESULTS
Thirty-seven DDL and 52 SL patients were evaluated. The mean follow-up period was 8 years and the follow-up rate was 46.8%. No significant differences were found regarding age and JOA score at baseline. At the follow-up, there were no significant differences in SF-36, JOACMEQ, and VAS score, while the NDI score for headache and sleeping were higher in the SL group. After dividing the SL group into short and long SL subgroups, the long SL subgroup showed a significantly lower score in bodily pain in SF-36, lower and bladder function in JOACMEQ, and pain intensity, personal care, headaches, and sleeping in NDI compared with the other groups.
CONCLUSION
No significant differences were found in SF-36, JOA score, and NDI, except for the NDI subscale of headache and sleeping. The subgroup analysis showed that the long SL group showed a decreased QOL compared with the short SL and DDL groups.
LEVEL OF EVIDENCE
3.

Identifiants

pubmed: 30059486
doi: 10.1097/BRS.0000000000002814
pii: 00007632-201902150-00006
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Pagination

E211-E218

Références

Karadimas SK, Erwin WM, Ely CG, et al. Pathophysiology and natural history of cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2013; 38:S21–36.
Fehlings MG, Wilson JR, Kopjar B, et al. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am 2013; 95:1651–1658.
Hirabayashi K, Watanabe K, Wakano K, et al. Expansive open-door laminoplasty for cervical spinal stenotic myelopathy. Spine (Phila Pa 1976) 1983; 8:693–699.
Shiraishi T. Skip laminectomy: a new treatment for cervical spondylotic myelopathy, preserving bilateral muscular attachments to the spinous processes: a preliminary report. Spine J 2002; 2:108–115.
Kurokawa T. Enlargement of spinal canal by sagittal splitting of the spinal processes [in Japanese]. Bessatsu Seikeigeka 1982; 2:234–240.
Kimura A, Seichi A, Inoue H, et al. Long-term results of double-door laminoplasty using hydroxyapatite spacers in patients with compressive cervical myelopathy. Eur Spine J 2011; 20:1560–1566.
Takayasu M, Takagi T, Nishizawa T, et al. Bilateral open-door cervical expansive laminoplasty with hydroxyapatite spacers and titanium screws. J Neurosurg 2002; 96:22–28.
Takebayashi T, Yoshimoto M, Ida K, et al. Minimum invasive posterior decompression for cervical spondylotic amyotrophy. J Orthop Sci 2013; 18:205–207.
Seichi A, Takeshita K, Ohishi I, et al. Long-term results of double-door laminoplasty for cervical stenotic myelopathy. Spine (Phila Pa 1976) 2001; 26:479–487.
Shiraishi T, Fukuda K, Yato Y, et al. Results of skip laminectomy-minimum 2-year follow-up study compared with open-door laminoplasty. Spine (Phila Pa 1976) 2003; 28:2667–2672.
Tsuji T, Asazuma T, Masuoka K, et al. Retrospective cohort study between selective and standard C3-7 laminoplasty. Minimum 2-year follow-up study. Eur Spine J 2007; 16:2072–2077.
Nakashima H, Kato F, Yukawa Y, et al. Comparative effectiveness of open-door laminoplasty versus French-door laminoplasty in cervical compressive myelopathy. Spine (Phila Pa 1976) 2014; 39:642–647.
Okada M, Minamide A, Endo T, et al. A prospective randomized study of clinical outcomes in patients with cervical compressive myelopathy treated with open-door or French-door laminoplasty. Spine (Phila Pa 1976) 2009; 34:1119–1126.
Lee DG, Lee SH, Park SJ, et al. Comparison of surgical outcomes after cervical laminoplasty: open-door technique versus French-door technique. J Spinal Disord Tech 2013; 26:E198–E203.
Kotani Y, Abumi K, Ito M, et al. Minimum 2-year outcome of cervical laminoplasty with deep extensor muscle-preserving approach: impact on cervical spine function and quality of life. Eur Spine J 2009; 18:663–671.
Otani K, Sato K, Yabuki S, et al. A segmental partial laminectomy for cervical spondylotic myelopathy: anatomical basis and clinical outcome in comparison with expansive open-door laminoplasty. Spine (Phila Pa 1976) 2009; 34:268–273.
Sivaraman A, Bhadra AK, Altaf F, et al. Skip laminectomy and laminoplasty for cervical spondylotic myelopathy: a prospective study of clinical and radiologic outcomes. J Spinal Disord Tech 2010; 23:96–100.
Yukawa Y, Kato F, Ito K, et al. Laminoplasty and skip laminectomy for cervical compressive myelopathy: range of motion, postoperative neck pain, and surgical outcomes in a randomized prospective study. Spine (Phila Pa 1976) 2007; 32:1980–1985.
Shiraishi T. A new technique for exposure of the cervical spine laminae. Technical note. J Neurosurg 2002; 96:122–126.
Yonenobu K, Abumi K, Nagata K, et al. Interobserver and intraobserver reliability of the Japanese Orthopaedic Association scoring system for evaluation of cervical compression myelopathy. Spine (Phila Pa 1976) 2001; 26:1890–1894. discussion 5.
Fukuhara S, Bito S, Green J, et al. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51:1037–1044.
Fukui M, Chiba K, Kawakami M, et al. Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): part 4. Establishment of equations for severity scores. Subcommittee on low back pain and cervical myelopathy, evaluation of the clinical outcome committee of the Japanese Orthopaedic Association. J Orthop Sci 2008; 13:25–31.
Vernon H, Mior S. The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther 1991; 14:409–415.
Mielke D, Rohde V. Bilateral spinal canal decompression via hemilaminectomy in cervical spondylotic myelopathy. Acta Neurochir (Wien) 2015; 157:1813–1817.
Dahdaleh NS, Wong AP, Smith ZA, et al. Microendoscopic decompression for cervical spondylotic myelopathy. Neurosurg Focus 2013; 35:E8.
Chiba K, Ogawa Y, Ishii K, et al. Long-term results of expansive open-door laminoplasty for cervical myelopathy: average 14-year follow-up study. Spine (Phila Pa 1976) 2006; 31:2998–3005.
Kawaguchi Y, Kanamori M, Ishihara H, et al. Minimum 10-year followup after en bloc cervical laminoplasty. Clin Orthop Relat Res 2003; 129–139.
Iizuka H, Shimizu T, Tateno K, et al. Extensor musculature of the cervical spine after laminoplasty: morphologic evaluation by coronal view of the magnetic resonance image. Spine (Phila Pa 1976) 2001; 26:2220–2226.
Tani S, Isoshima A, Nagashima Y, et al. Laminoplasty with preservation of posterior cervical elements: surgical technique. Neurosurgery 2002; 50:97–101.
Machino M, Yukawa Y, Hida T, et al. Modified double-door laminoplasty in managing multilevel cervical spondylotic myelopathy: surgical outcome in 520 patients and technique description. J Spinal Disord Tech 2013; 26:135–140.
Zhang J, Tsuzuki N, Hirabayashi S, et al. Surgical anatomy of the nerves and muscles in the posterior cervical spine: a guide for avoiding inadvertent nerve injuries during the posterior approach. Spine (Phila Pa 1976) 2003; 28:1379–1384.
Suda K, Abumi K, Ito M, et al. Local kyphosis reduces surgical outcomes of expansive open-door laminoplasty for cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2003; 28:1258–1262.
Fujimori T, Iwasaki M, Okuda S, et al. Long-term results of cervical myelopathy due to ossification of the posterior longitudinal ligament with an occupying ratio of 60% or more. Spine (Phila Pa 1976) 2014; 39:58–67.

Auteurs

Ryosuke Hirota (R)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Naohisa Miyakoshi (N)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Mitsunori Yoshimoto (M)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Michio Hongo (M)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Shuto Hamada (S)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Yuji Kasukawa (Y)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Tsutomu Oshigiri (T)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Yoshinori Ishikawa (Y)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Noriyuki Iesato (N)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Daisuke Kudo (D)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Katsumasa Tanimoto (K)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Yoshinori Terashima (Y)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Tsuneo Takebayashi (T)

Department of Orthopaedic Surgery, Sapporo Maruyama Orthopedic Hospital, Sapporo, Japan.

Yoichi Shimada (Y)

Department of Orthopaedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Toshihiko Yamashita (T)

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH